- Made Scientific and RoosterBio have formed a strategic partnership to integrate MSC and extracellular vesicle manufacturing platforms into Made Scientific’s CDMO services.
- The collaboration combines process development, GMP manufacturing, and supply chain capabilities to support advanced therapy developers from clinical development through commercialization.
Made Scientific, Inc. and RoosterBio have announced a strategic partnership to integrate mesenchymal stem cell (MSC) and extracellular vesicle (EV) manufacturing platforms into Made Scientific’s end-to-end CDMO offering.
Under the agreement, Made Scientific will incorporate RoosterBio’s off-the-shelf MSCs, MSC expansion media, EV collection media, and bioprocess expertise into its GMP operations. The companies stated that the integrated platform is designed to support sponsors developing therapies based on MSCs and MSC-derived EVs while reducing development timelines and manufacturing costs.
The manufacturing platform supports multiple production systems, including Corning CellSTACK®, Eppendorf BioFlo® 320, Sartorius Biostat STR®, Terumo BCT Quantum Flex™, and PBS Biotech vertical-wheel bioreactors. Made Scientific said flask-based production currently supports up to 40xCS10 scale, while technology transfer activities for single-use bioreactor production are advancing toward client readiness in the second quarter of 2026.
Made Scientific operates a 60,000-square-foot FDA-registered GMP manufacturing facility in Princeton, New Jersey, focused on clinical and commercial cell therapy production. The partnership also integrates RoosterBio’s process development capabilities from its Frederick, Maryland laboratories into Made Scientific’s GMP workflows to support a streamlined pathway from development to commercial manufacturing.
“This partnership gives our clients a fully integrated, scientifically rigorous pathway from development through commercial supply — combining RoosterBio’s proven MSC platform with Made Scientific’s GMP manufacturing, quality systems, and regulatory expertise.”
Syed T. Husain, Chairman and CEO of Made Scientific
